Sionna Therapeutics (SION) Current Assets (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Current Assets data on file, last reported at $221.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 19.26% year-over-year to $221.0 million; the trailing twelve-month figure through Mar 2026 stood at $221.0 million (down 19.26% YoY), and the FY2025 full-year result was $241.4 million, up 59.89% from the prior year.
• Current Assets eased to $221.0 million in Q1 2026, from $241.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $273.7 million in Q1 2025 to a low of $151.0 million in Q4 2024.
• A 3-year average of $234.4 million and a median of $246.9 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 59.89% in 2025 and slipped 19.26% in 2026, its largest moves.
• Tracing SION's Current Assets over 3 years: stood at $151.0 million in 2024, then jumped by 59.89% to $241.4 million in 2025, then fell by 8.47% to $221.0 million in 2026.
• Business Quant data shows SION's Current Assets at $221.0 million in Q1 2026, $241.4 million in Q4 2025, and $252.3 million in Q3 2025.